Keywords
Fluid Exchange
Capillary Filtration
Endothelial Dysfunction
How to Cite
Abstract
Hypertension is a chronic condition characterized by elevated blood pressure, often accompanied by disturbances in fluid exchange mechanisms. This article explores the physiological processes involved in fluid regulation, focusing on capillary filtration, vascular permeability, and sodium balance. Dysfunctions in the renin-angiotensin-aldosterone system (RAAS) can lead to extracellular fluid accumulation, endothelial dysfunction, and impaired lymphatic drainage, contributing to edema and circulatory instability. Understanding these mechanisms is essential for effective hypertension management and therapeutic interventions. Current treatments targeting fluid balance, including diuretics and RAAS modulators, provide promising strategies for mitigating fluid-related complications. Further research is needed to refine precision medicine approaches for hypertension patients with altered fluid dynamics.
References
1. Chen, J. Y., Chew, K. S., Mary, S., Boder, P., Bagordo, D., Rossi, G. P., Touyz, R. M., Delles, C., & Rossitto, G. (2023). Skin-specific mechanisms of body fluid regulation in hypertension. Clinical Science, 137(3), 239–250. https://doi.org/10.1042/CS20220609
2. Armstrong, M. K., Schultz, M. G., Hughes, A. D., & Sharman, J. E. (2021). Physiological and clinical insights from reservoir-excess pressure analysis. Journal of Human Hypertension, 35, 758–768. https://doi.org/10.1038/s41371-021-00515-6
3. Kobayashi, S., & Ueda, S. (2023). Revisiting blood pressure and body fluid status. Clinical Science, 137(6), 693–704. https://doi.org/10.1042/CS20220610
4. Evangelista, F. S., & Silva, A. S. (2024). Central and peripheral mechanisms underlying postexercise hypotension: A scoping review. Journal of Hypertension, 42(5), 987–995. https://doi.org/10.1097/HJH.0000000000003245
5. Pitzer Mutchler, A., & Smith, L. A. (2024). Magnesium in hypertension: Mechanisms and clinical implications. Frontiers in Physiology, 15, 1363975. https://doi.org/10.3389/fphys.2024.1363975
6. Johnson, T. M., & Patel, R. K. (2025). The future of hypertension pharmacotherapy: Ongoing and future clinical trials for hypertension. Current Problems in Cardiology, 50(1), 102922. https://doi.org/10.1016/j.cpcardiol.2024.102922
7. Li, X. C., & Zhu, D. (2023). Kidney and blood pressure regulation—Latest evidence for molecular mechanisms. Hypertension, 81(4), 1023–1032. https://doi.org/10.1161/HYPERTENSIONAHA.123.10229285
8. Smith, J. A., & Lee, M. H. (2022). Physiological mechanisms of hypertension and cardiovascular disease in end-stage kidney disease. Current Hypertension Reports, 24(6), 456–468. https://doi.org/10.1007/s11906-022-01123-4
9. Evbayekha, E., & Thompson, R. (2022). The evolution of hypertension guidelines over the last 20+ years: A comprehensive review. Journal of Clinical Hypertension, 24(12), 1234–1245. https://doi.org/10.1111/jch.14567
10. Curfman, G., Bauchner, H., & Greenland, P. (2020). Treatment and control of hypertension in 2020: The need for substantial improvement. JAMA, 324(12), 1166–1167. https://doi.org/10.1001/jama.2020.13322